Academic literature on the topic 'Maladie de Parkinson – Psychologie'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Maladie de Parkinson – Psychologie.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Maladie de Parkinson – Psychologie"
Nadeau, Dominic, Isabelle Giroux, Julie Dufour, and Martine Simard. "Jeu pathologique chez les patients atteints de la maladie de Parkinson." Santé mentale au Québec 37, no. 1 (October 3, 2012): 189–202. http://dx.doi.org/10.7202/1012651ar.
Full textBatselé, Élise, Hélène Geurts, Elise Buchet, Marie-Claire Haelewyck, and Mathilde Boutiflat. "Maladie de Parkinson et besoins en matière d’outils technologiques de soutien à la communication : étude qualitative." L’Année psychologique Vol. 124, no. 1 (March 11, 2024): 79–100. http://dx.doi.org/10.3917/anpsy1.241.0079.
Full textBallarin-Chamillard, Emmanuelle. "Une « chaise vide » pour travailler avec les familles affectées par une maladie neuro-évolutive." Cahiers critiques de thérapie familiale et de pratiques de réseaux 71, no. 2 (October 26, 2023): 109–25. http://dx.doi.org/10.3917/ctf.071.0109.
Full textRuppert, Elisabeth, Leopold Muller, Ludivine Robin-Choteau, Bernadette Kowalski, Marc Bataillard, Ouhaïd Lagha-Boukbiza, Christine Tranchant, and Patrice Bourgin. "Étude des rythmes circadiens dans la Maladie de Parkinson." Médecine du Sommeil 18, no. 1 (March 2021): 36. http://dx.doi.org/10.1016/j.msom.2020.11.056.
Full textDupouy, Julia, Fabienne Ory-Magne, and Christine Brefel-Courbon. "Autres prises en charge dans la maladie de Parkinson : psychologique, rééducative, éducation thérapeutique et nouvelles technologies." La Presse Médicale 46, no. 2 (March 2017): 225–32. http://dx.doi.org/10.1016/j.lpm.2016.11.009.
Full textPlomhause, L., K. Dujardin, A. Duhamel, L. Defebvre, P. Derambure, and C. Monaca Charley. "Troubles du comportement en sommeil paradoxal dans la maladie de Parkinson débutante." Médecine du Sommeil 10, no. 2 (April 2013): 47. http://dx.doi.org/10.1016/j.msom.2013.03.005.
Full textGronchi-Perrin, Aline, and François Vingerhoets. "Effets cognitivo-comportementaux de la stimulation cérébrale profonde dans la maladie de Parkinson." Revue de neuropsychologie Volume 1, no. 1 (March 1, 2009): 59–63. http://dx.doi.org/10.1684/nrp.2009.0008.
Full textMontel, S., and C. Bungener. "Les troubles anxiodépressifs dans la maladie de Parkinson: une revue de la littérature." Annales Médico-psychologiques, revue psychiatrique 166, no. 2 (March 2008): 85–92. http://dx.doi.org/10.1016/j.amp.2006.04.014.
Full textFigorilli, Michela, Ana-Raquel Marques, Mario Meloni, Bruno Pereira, Monica Puligheddu, Franck Durif, and Maria Livia Fantini. "Étude longitudinale du trouble comportemental en sommeil paradoxal dans la maladie de Parkinson." Médecine du Sommeil 17, no. 1 (March 2020): 72–73. http://dx.doi.org/10.1016/j.msom.2019.12.111.
Full textRuppert, Elisabeth, Leopold Muller, Ludivine Robin-Choteau, Bernadette Kowalski, Marc Bataillard, Ouhaïd Lagha-Boukbiza, Christine Tranchant, and Patrice Bourgin. "Évaluations objective et subjective du sommeil et de la somnolence dans la maladie de Parkinson." Médecine du Sommeil 18, no. 1 (March 2021): 29. http://dx.doi.org/10.1016/j.msom.2020.11.034.
Full textDissertations / Theses on the topic "Maladie de Parkinson – Psychologie"
Delgadillo, Iniguez Luis Daniel. "Troubles de la Motivation et Maladies Neurovégétatives : l'Apathie dans la maladie de Parkinson et la Sclérose Latérale Amyotrophique." Montpellier 3, 2007. http://www.theses.fr/2007MON30042.
Full textApathy is a motivation disorder that has an important influence in the emotional domain. Studies published concerning the relationship between apathy and cognitive and emotional disorders are not exhaustive. No comparisons have been established according to the different kinds of neurological diseases. The objective of this study is to demonstrate the heterogeneity of the apathetic syndrome and it’s mechanisms in different progressive neurological diseases (Parkinson’s disease and Amyotrophic Lateral Sclerosis (ALS) and to analyze the relationship between apathy and cognitive and emotional disturbances. We also studied the motivation disturbances using a new scale developed by Derouesné et al. (2004) that allowed a qualitative analysis of motivation. The results agree with previous studies and showed the heterogeneity of apathy in the two studies diseases. This heterogeneity is explained by the relationship of the apathy with the emotional data but not by the cognitive data. The qualitative analysis of the motivation allowed a better understanding of the apathy mechanisms and showed that patients with Parkinson’s disease attribute their reduction of activity to a real lack of motivation and ALS patients to the motor handicap induced by the disease
Evrard, Christelle. "L'importun, c'est la rose ? : Contribution à l'étude des intrusions mnésiques dans le cadre du vieillissement normal et pathologique." Nantes, 2013. http://www.theses.fr/2013NANT3035.
Full textNadeau, Dominic. "Portrait des habitudes de jeu de patients atteints de la maladie de Parkinson." Doctoral thesis, Université Laval, 2016. http://hdl.handle.net/20.500.11794/26872.
Full textThe risk of developing a gambling disorder in Parkinson’s disease (PD) is increasingly documented. A type of drug that control motor symptoms, the dopamine agonist, is one of the main factors related to the development of this disorder. Through a narrative synthesis presented in chapter 3, the neurobiological mechanisms and other related factors are discussed. However, an important finding is clear: the study of gambling habits of these patients is virtually absent. This is surprising since the gambling literature is packed with information to consider in the development of this disorder, such as type of game played, amounts spent, reasons to play and the presence of relatives. The second article aims to address this deficiency by establishing a portrait of their gambling habits. Twenty-five people with PD were recruited and among these, fifteen have gambled in the last six months. The review of their gambling habit reveals that favorite games are lottery and slot machine and they mostly started playing these games before the diagnosis of PD. They are less interested in playing slot machines compared to a sample of players aged over 55 but, in return, this game is the one to which the largest amounts were spent in participants who reported having developed a gambling problem. Participants reported gambling for fun or to make money, but several reasons related to their disease have been identified. These patients did not seek help of caregivers to assist them in the practice of their favorite game. Moreover, these caregivers revealed their ignorance of the participant’s gambling habits. Among all participants met, three of them were at risk gamblers. In addition to playing slot machines, erroneous beliefs and specific motivations to gamble were found among these. The reflection from these results will stimulate research in the study of the psychosocial variables related to the development of gambling problems in these patients.
Bocquillon, Perrine. "Approche psycho-physiologique des troubles attentionnels dans la maladie de Parkinson." Thesis, Lille 2, 2012. http://www.theses.fr/2012LIL2S009.
Full textParkinson’s disease (PD) is a frequent neurodegenerative disease which is responsible for striatal dopaminergic depletion. PD patients present an early cognitive impairment, particularly attentional disorders. The origin of this impairment is still debated. It could result from a reduced allocation of attentional resources to the ongoing task (“top-down” process (TD)) or a defective inhibition of irrelevant events (failure of “bottom-up” filtering process (BU). Investigation of attentional processes mostly rely on behavioral analysis, but the study of the N200 and P300 components of the cognitive event-related potentials (ERPs) may be of interest. P300 can be divided into two subcomponents: (1) P3a, which occurs preferentially after distracter stimuli and is associated with BU processes; (2) P3b, related to target detection and associated with TD mechanisms. The N200 also comprises two main components: an anterior “no-go-N2", involved in mismatch detection and inhibition mechanisms, and a posterior “go-N2”, related to target categorization processes. Most of previous studies in PD have shown a longer latency and reduced amplitude of N200 and P300. To the best of our knowledge, modulation of their generators in PD has never been investigated. The main aim of this work was to improve our knowledge of the mechanisms of attention disorders in PD. If the attentional impairment in PD results from a failure of TD processes, this would result in modifications of the networks underlying the P3b and/or the posterior N2 during target detection. Alternatively, if this disorder is consecutive to a failure of BU processes, this would lead to difficulty in resisting interference from distracter stimuli and would change the characteristics of the P3a and/or anterior N200. ERPs were recorded in 15 young healthy subjects with high resolution electroencephalography during a three stimuli oddball paradigm in order to localize N200 and P300 generators in healthy subjects. Then, they were recorded with the same procedure in 15 patients with PD and 15 matched healthy controls. Group comparisons of the ERPs latency and amplitude were performed with analyses of variance. Generators of the ERPs components were identified for each subject and in each condition with a distributed source localization method, swLORETA (standardized weighted low resolution tomography). Group analyses of swLORETA solutions were performed with SPM® for the P300 subcomponents and with a permutation method for the N200. In young healthy controls, we showed an involvement of the dorsal frontoparietal (DFP) network in both P3a and P3b generation, while the ventral frontoparietal network was specific to target processing. The anterior cingulate cortex (ACC) that interacts with the frontoparietal networks, had a preponderant role in N200 generation. Other areas, namely the precuneus and the posterior cingulate cortex, which are connected to the ACC, are specific generators of some of the N200 subcomponents. In PD, a reduction of distracter-elicited P300 generators was found in the dorsolateral prefrontal cortex (DLPF), which is part of the DFP network, accordingly with an increased commission rate for distracter stimuli. These results suggest a failure of BU processes in PD. A reduced number of N200 generators was also displayed in both DLPF and ACC whatever the stimulus. This suggests a dysfunction of both the DLPF and the ACC at an early stage of attentional processes in PD, while only distracter processing was later impaired, in relation with a DLPF dysfunction. These abnormalities probably result from disturbances of the basocortical loops that link the associative striatum to the DLPF and ACC. This would then produce a sustainable alteration of cognitive control and BU processes, responsible for abnormal mismatch detection and inhibition of irrelevant stimuli, which would underlie the selective attention impairment in PD
Robert, Gabriel. "Apathie et émotions : corrélats cliniques et métaboliques dans la maladie de Parkinson et la Schizophrénie." Rennes 1, 2012. http://www.theses.fr/2012REN1B011.
Full textApathy metabolic bases and its correlations with emotional recognition remain unknown whereas both have been described in Parkinson’s Disease (PD) and schizophrenia. We highlight apathy metabolic bases within 45 PD patients (without dementia and depression) with 18-fluorodeoxyglucose positron emission tomography. Reults show that ventro-lateral prefrontal cortex (PFC), orbitofrontal cortex (OFC), the the precuneus and cerebellum are involved. Cognitive dimension show the same pattern. The emotional dimension show that the Premotor Cortex (PMC), the dorso- lateral PFC, posterior cingulate (PC) and superior temporal sulcus are involved. The behavioural dimension do not rely on specific cerebral network. However, all dimensions involve the cerebellum posterior lobes. In another sample of 36 PD patients, we find a significant relationship between apathy and altered facial emotional recognition. This correlation relies on a specific network that involves the PMC, the OFC and the PC. Preliminary results on schizophrenia find decreased performances in apathetic patients on an auditive emotional recognition task,compared to non apathetic schizophrenia patients and controls, although not significant. This may come from the difference between the two samples of patients and push us to continue to enroll apathetic patients. Liietrature data on apathy functionnal anatomy is discussed
Carey, Guillaume. "Imaging anxiety in Parkinson's disease." Electronic Thesis or Diss., Université de Lille (2022-....), 2024. https://pepite-depot.univ-lille.fr/ToutIDP/EDBSL/2024/2024ULILS023.pdf.
Full textAnxiety in Parkinson's disease (PD) is a frequent and disabilitating non-motor symptom. It is difficult to manage, partly due to a poor knowledge of the underlying mechanisms. The objective of this thesis was to identify the underlying mechanisms of PD-related anxiety, using multimodal brain MRI.A systematic review of the literature on imaging data in PD-related anxiety was first carried out, allowing the generation of initial hypotheses. Then, several studies including structural and functional brain MRI analyses were carried out in PD patients with or without clinically significant anxiety. Our analyses focused on the fear circuit, known to be involved in anxiety disorders and fear processing, and the limbic cortico-striato-thalamo-cortical circuit, known for its involvement in the neuropsychiatric symptoms of PD.Our results suggest that PD-related anxiety is the consequence of a functional and structural imbalance between these two circuits. Certain overlapping structures, such as the thalamus, the striatum or the brainstem nuclei, could be key areas whose alteration could explain the high prevalence of these disorders in PD. Further works based in particular on technological advances in imaging and new concepts concerning the pathophysiology of PD will be necessary to answer the remaining questions
Montel, Sébastien. "Coping et qualité de vie en lien avec l'humeur et les émotions dans la sclérose en plaques et Parkinson." Paris 5, 2007. http://www.theses.fr/2007PA05H046.
Full textMultiple Sclerosis (MS) and Parkinson's Disease (PD) are two neurological disorders having a significant effect on the Quality of Life (QoL) of subjects affected by them. The fonctional limitations compel the patients to revise their priorities and to accept many changes in their daily life. Mood disorders linked on the one hand to the consequences of the disease and on the other hand to neurological lesions, frequently follow. To face this physical, psychological and social upheaval, subjects use coping strategies. This work aims to study the coping style and the QoL of MS and PD subjects while taking account of depression and anxiety. We thought that some coping strategies could be linked to a poor QoL. We expected different coping strategies according to the type of disease and its clinical characteristics. The research include 3 studies and one clinical reflexion. One hundred thirty five MS in the first study, 135 PD in the second one and 40 PD who have undergone a deep brain stimulation are evaluated. The collect of data is made through a semi-structured interview and self-questionnaires. The research bring out different coping strategies according to the disease but also according to the clinical course in MS and motor signs as well stimulation in PD. Emotional coping strategies are linked to a poor QoL in overall patients. These results encourage us to develop multi-focused interventions adapted to the disease's characteristics
Mondon, Karl. "Etude phénotypique des démences extrapyramidales : apport de la neuropsychologie dans le diagnostic différentiel." Thesis, Tours, 2011. http://www.theses.fr/2011TOUR3146.
Full textClinical manifestations associating motor and cognitive impairment are frequently encountered and difficult for the clinician who is required to address the problem of making the correct differential diagnosis, particularly to differentiate Parkinson's disease with dementia (PDD) from Lewy bodies dementia (LBD). In this study, we examined the neuropsychological characteristics which allow us to differentiate the two disorders. In the first study, we demonstrated that visual recognition memory is disturbed differently in the two cases. In a second study, we specified the characterisstics of the modifications encountered by using the classic "cortical" and "subcortical" dementia profiles. We also showed that, in PDD, the alteration in visual recognition memory is intermediary between Alzheimer's disease and LBD. Finally, in the last part of our study, we suggest future avenues of research needed to complete our work
Péran, Patrice. "Traitement des verbes : Etude neuropsychologique dans les pathologies sous-corticales : étude de neuroimagerie fonctionnelle et pharmacologique chez des sujets sains." Toulouse 2, 2004. http://www.theses.fr/2004TOU20043.
Full textThe aim of this thesis is two-fold : 1) to characterize verb processing in relation to the fronto-striatal pathophysiology comparing noun- and verb- generation tasks in 34 non demented Parkinson's Disease (PD) patients, non demented and demented Huntington's Disease (HD) with matched control subjects 2) to assess, using fMRI, the effects of paroxetine on brain activity during language tasks related to action processing in healthy subjects after one-month treatment. 1) Our study evidences a clear language deficit in non-demented PD patients in tasks designed to explore verb processing. The profile of HD results is different since non demented and demented HD patients have showed a deficit whatever the task in comparison with control groups. 2) Our fMRI results show that paroxetine induces a relative enhancement of cortical activity for a low-level automatized language task, and a relative decrease of cortical activity for the two demanding tasks
Giguère-Rancourt, Ariane. ""Goal Management Training" : effets d'un programme d'entraînement des fonctions exécutives chez des patients atteints de la maladie de Parkinson idiopathique." Doctoral thesis, Université Laval, 2021. http://hdl.handle.net/20.500.11794/69591.
Full textParkinson's disease (PD) is a neurodegenerative disease characterised by resting tremor and rigidity. In addition to these motor symptoms of PD, other non-motor symptoms occur, such as cognitive deficits. Approximately 30% of PD patients develop Mild Cognitive Impairment (MCI) with executive dysfunction, that is, difficulties in executive functions. These functions are the ability to organize and coordinate thoughts, goal directed behaviors and to regulate emotions. Few treatments are actually available specifically for cognitive impairment in PD patients. Since medication development can take several years and cause adverse side effects, other non-pharmacological treatments may be useful in helping patients with PD-MCI. This thesis aims to evaluate two non-pharmacological approaches (cognitive training and psychoeducation), which were adapted to patients with PD-MCI. In order to meet certain limitations of previous studies, the Goal Management Training (GMT) training program was chosen for administration to PD-MCI patients with executive dysfunction. Another program was developed in form of psychoeducation on PD and various symptoms, coupled with mindfulness exercises. The first study intended to adapt the GMT program to PD-MCI population. With a multi baseline case study in a first patient, safety and acceptability were verified on several parameters (fatigue, psychological and behavioral symptoms, changes in medication or dosage and caregiver burden). The results show that GMT is safe and acceptable. In addition, it improves concerns about executive functions. The second study assessed the effects of the two programs (executive functions, quality of life, overall cognition) with a randomized - control study. Six patients received the adapted GMT, and six others received the combination of psychoeducation and mindfulness. The programs were administered at the home of each participant in the presence of the caregiver, in five sessions of 60-75 minutes, over five weeks. Various follow-up measures were taken at one, four and 12 weeks after the end of the intervention. The results show that both programs improved concerns about executive functions. They also reduced the number of errors made in an executive functions task, with a non-significant trend towards greater improvement in the GMT group. After four weeks, the group combining psychoeducation and mindfulness saw an improvement in quality of life, whereas scores of the GMT group were maintained. This study shows the interest of non-pharmacological approaches. Each program has its advantages and limitations depending on the profile of each participant. The third study aimed to include caregiver's data. During the second study, the caregivers of each participant answered questionnaires on the feelings of burden and distress. First, all data from the baseline, before randomization and interventions, were combined. The associations between clinical variables and variables in caregivers were assessed with a correlation matrix. Secondly, the effects of the two interventions were specifically evaluated on caregiver's measures. The results show there was no deterioration in feelings of burden and distress among caregivers for any of the groups, even if they had to invest time during the interventions. This study showed the importance of involving caregivers in the therapeutic process of PD-MCI patients. This thesis has shown the potential of two non-pharmacological approaches to improve concerns of patients with cognitive disorders. The three studies show limits, as well as strengths. Different theoretical and clinical recommendations regarding the intervention in people with PD-MCI can be considered.
Books on the topic "Maladie de Parkinson – Psychologie"
Zagnoli, Fabien. Maladie de Parkinson. 2nd ed. Rueil-Malmaison: Doin, 2006.
Find full textPollak, Pierre. La maladie de Parkinson. Paris: O. Jacob, 2000.
Find full textPollak, Pierre. La maladie de Parkinson. Paris: O. Jacob, 2004.
Find full textJacques, Pelissier, ed. Maladie de Parkinson et rééducation. Paris: Masson, 1990.
Find full textPatenaude, Diane. À nous deux, Parkinson!: Chroniques humoristiques pour apprivoiser la maladie de Parkinson. Saint-Sauveur, Québec: Marcel Broquet, 2009.
Find full textFoucault, Michel. Maladie mentale et psychologie. 2nd ed. Paris: Presses universitaires de France, 1997.
Find full textMesplé, Mady. La voix du corps: Vivre avec la maladie de Parkinson. Neuilly-sur-Seine: Lafon, 2010.
Find full textFriedman, Joseph H. Making the Connection between Brain and Behavior: Coping with Parkinson's Disease. New York, NY: Demos Health, 2008.
Find full textGerald, Stern. Parkinson's disease: The facts. Oxford [England]: Oxford University Press, 1990.
Find full textC, Duvoisin Roger. Parkinson's disease: A guide for patient and family. 3rd ed. New York: Raven Press, 1991.
Find full textBook chapters on the topic "Maladie de Parkinson – Psychologie"
Herbaut, A. G. "La maladie de Parkinson." In Les incontinences urinaires de l’homme, 201–4. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-287-99160-8_19.
Full textVelly, Lionel, and Nicolas Bruder. "Réanimation et maladie de Parkinson." In Maladies rares en réanimation, 177–90. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-287-99070-0_16.
Full text"Comment la maladie de Parkinson est-elle liée au traitement de l’information temporelle ?" In Le temps psychologique en questions, 143–50. Les Presses de l’Université de Laval, 2017. http://dx.doi.org/10.1515/9782763737096-018.
Full text"Maladie de Parkinson." In Méga Guide STAGES IFSI, 1094–101. Elsevier, 2015. http://dx.doi.org/10.1016/b978-2-294-74529-4.00341-4.
Full textAlexandre, J., A. Balian, L. Bensoussan, A. Chaïb, G. Gridel, K. Kinugawa, F. Lamazou, et al. "Maladie de Parkinson." In Le tout en un révisions IFSI, 995–1001. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70633-2.50333-4.
Full textRoche, Yvon. "Maladie de Parkinson." In Risques médicaux au cabinet dentaire en pratique quotidienne, 599–608. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-70866-4.00039-0.
Full textHuang, Xuemei, Lars Peter Jacobson, and J. Douglas Mann. "Maladie de Parkinson." In Médecine interne de Netter, 1001–7. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-70951-7.00130-4.
Full textHallouët, Pascal. "Maladie de Parkinson." In Mémo-guide infirmier, 255–58. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71154-1.50039-1.
Full textHallouët, Pascal. "Maladie de Parkinson." In Méga Mémo IFSI, 1180–84. Elsevier, 2016. http://dx.doi.org/10.1016/b978-2-294-74924-7.50173-1.
Full textGochard-Rodrigues, Alice. "Maladie de Parkinson." In Gériatrie, 520–26. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77815-5.00061-5.
Full textConference papers on the topic "Maladie de Parkinson – Psychologie"
Delvaux, Véronique, Bernard Harmegnies, Kathy Huet, Myriam Piccaluga, Virginie Roland, and Clémence Verhaegen. "Les personnes atteintes de la maladie de Parkinson font preuve de flexibilité phonétique." In XXXIVe Journées d'Études sur la Parole -- JEP 2022. ISCA: ISCA, 2022. http://dx.doi.org/10.21437/jep.2022-31.
Full textOliveira, Kathia Marçal de, Taisa Guidini Gonçalves, Christophe Kolski, Sophie Lepreux, Véronique Delcroix, Nejmeddine Allouche, Yohan Guerrier, and Philippe Pudlo. "Évaluation initiale d’un outil d’aide à la communication pour des personnes atteintes de la maladie de Parkinson." In IHM '22: 33e conférence internationale francophone sur l'Interaction Humain-Machine. New York, NY, USA: ACM, 2022. http://dx.doi.org/10.1145/3502178.3529112.
Full textVaysse, Robin, Alain Ghio, Corine Astésano, Jérôme Farinas, and François Viallet. "Analyse macroscopique des variations et modulations de F0 en lecture dans la maladie de Parkinson : données sur 320 locuteurs." In XXXIVe Journées d'Études sur la Parole -- JEP 2022. ISCA: ISCA, 2022. http://dx.doi.org/10.21437/jep.2022-33.
Full textContreras Roa, Leonardo, Paolo Mairano, Caroline Moreau, and Anahita Basirat. "Impact de l’amorçage rythmique sur la production de la parole chez des personnes atteintes de la maladie de Parkinson : Étude pilote." In XXXIVe Journées d'Études sur la Parole -- JEP 2022. ISCA: ISCA, 2022. http://dx.doi.org/10.21437/jep.2022-61.
Full textLepreux, Sophie, Kodzo Apedo, and Kathia Marcal de Oliveira. "Vers une conception centrée sur l’utilisateur ayant un profil évolutif: Une étude de cas avec des personnes atteintes de la maladie de Parkinson." In IHM '21: IHM '21 - 32e Conférence Francophone sur l'Interaction Homme-Machine. New York, NY, USA: ACM, 2021. http://dx.doi.org/10.1145/3451148.3458646.
Full text